Prospective study on the recurrence/metastasis of stage II/III colorectal cancer and gastric cancer associated with occult neoplastic cells in lymph node sinuses: Three-year interim results

Oncology Reports

Volumn 16, Issue 2, 2006, Pages 405-410

  Mukai, Masaya ^a   Tajima, Takayuki ^a   Sato, Shinkichi ^b   Ninomiya, Hiromi ^b   Wakui, Kanako ^b   Komatsu, Nobukazu ^b   Tsuchiya, Kazutoshi ^b   Nakasaki, Hisao ^b   Makuuchi, Hiroyasu ^c  

^a TOKAI UNIVERSITY HACHIOJI HOSPITAL   (Japan)

^b TOKAI UNIVERSITY OISO HOSPITAL   (Japan)

^c TOKAI UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Gastric cancer; High risk group; Isolated tumor cells; Metastasis; Micro metastasis; Occult neoplastic cells; Recurrence

Indexed keywords

ARTICLE; CANCER STAGING; COLORECTAL TUMOR; HUMAN; LYMPH NODE; METASTASIS; MORTALITY; PATHOLOGY; PROSPECTIVE STUDY; RISK; STOMACH TUMOR; TUMOR RECURRENCE;

COLORECTAL NEOPLASMS; HUMANS; LYMPH NODES; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; RISK; STOMACH NEOPLASMS;

EID: 33748578005     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.2.405     Document Type: Article

References (38)

1. Journal of Health and Welfare Statistics, Health and Welfare Statistics Association, Tokyo, 51: 46-49, 2004.
2. Omejc M, Juvan R, Jelenc F and Repse S: Lymph node metastases in gastric cancer: correlation between new and old UICC TNM classification. Int Surg 86: 14-19, 2001. (Pubitemid 33594597)
3. Goldhirsch A, Glick JH, Gelber RD, Coates AS and Senn H-J: Meeting highlights: International consensus panel on the treatment of primary breast cancer. J Clin Oncol 19: 3817-3827, 2001. (Pubitemid 32880060)
4. Multi-institutional registry of large bowel cancer in Japan, cases treated in 1994. In: Japanese Society for Cancer of the Colon and Rectum. Vol. 23, Tokyo, 2002.
5. Prenzel KL, Mönig SP, Sinning JM, Baldus SE, Brochhagen H-G, Schneider PM and Hölscher AH: Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest 123: 463-467, 2003. (Pubitemid 36269431)
6. Mukai M, Ito I, Mukoyama S, Tajima T, Saito Y, Nakasaki H, Sato S and Makuuchi H: Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study. Oncol Rep 10: 927-934, 2003.
7. Mukai M, Sato S, Komatsu N, Nishida T, Shiba K, Ito I, Nakasaki H and Makuuchi H: Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with Dukes' C colorectal cancer. Oncol Rep 10: 1165-1169, 2003.
8. Mukai M, Sato S, Komatsu N, Nishida T, Shiba K, Ito I, Nakasaki H and Makuuchi H: Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with curatively resected Dukes' B colorectal cancer. Oncol Rep 10: 1177-1181, 2003.
9. Mukai M, Sato S, Nishida T, Komatsu N, Shiba K, Nakasaki H and Makuuchi H: Selection criteria for high-risk and low-risk groups of recurrence and metastasis in patients with primary colorectal cancer. Oncol Rep 10: 1753-1758, 2003.
10. Mukai M, Sato S, Nakasaki H, Saito Y, Nishiumi N, Iwasaki M, Tokuda Y, Ogoshi K, Inoue H, and Makuuchi H: Occult neoplastic cells in the lymph node sinuses and recurrence of primary breast, lung, esophageal and gastric cancer. Oncol Rep 11: 81-84, 2004.
11. Mukai M, Sato S, Komatsu N, Kimura T, Ninomiya H, Nakasaki H, Ogoshi K and Makuuchi M: Accuracy of criteria for predicting the recurrence and metastasis of stage I and II gastric cancer without lymph node metastasis. Oncol Rep 12: 59-62, 2004.
12. Mukai M, Sato S, Komatsu N, Kimura T, Ninomiya H, Nakasaki H, Ogoshi K and Makuuchi H: Accuracy of criteria for predicting recurrence and metastasis in stage II and III gastric cancer with lymph node metastasis. Oncol Rep 12: 63-66, 2004.
13. Mukai M, Sato S, Komatsu N, Kimura T, Ninomiya H, Nakasaki H, Ogoshi K and Makuuchi H: Predicting the recurrence/metastasis of stage II and III breast cancer with lymph node metastasis. Oncol Rep 12: 303-306, 2004.
14. Mukai M, Sato S, Komatsu N, Kimura T, Ninomiya H, Nakasaki H, Ogoshi K and Makuuchi H: Predicting the recurrence/metastasis of stage I and II breast cancer without lymph node metastasis. Oncol Rep 12: 745-748, 2004.
15. Mukai M, Sato S, Tajima T, Kimura T, Komatsu N, Ninomiya H, Nakasaki H, Ogoshi K and Makuuchi H: Predicting recurrence and metastasis of stage II/Dukes' B colorectal cancer without lymph node metastasis. Oncol Rep 12: 1127-1130, 2004.
16. Mukai M, Sato S, Tajima T, Kimura T, Komatsu N, Ninomiya H, Nakasaki H, Ogoshi K and Makuuchi H: Predicting recurrence and metastasis of stage III/Dukes' C colorectal cancer with lymph node metastasis. Oncol Rep 12: 1301-1304, 2004.
17. Mukai M, Sato S, Tajima T, Kimura T, Komatsu N, Ninomiya H, Nakasaki H, Ogoshi K and Makuuchi H: Predicting recurrence and metastasis of Dukes' A primary colorectal cancer with or without proper muscle invasion. Oncol Rep 12: 1305-1308, 2004.
18. Tajima T, Mukai M, Sato S, Wakui K, Ninomiya H, Komatsu N, Nakasaki H and Makuuchi H: Predicting recurrence and metastasis of primary esophageal cancer with or without lymph node metastasis. Oncol Rep 15: 809-814, 2006.
19. TNM Classification of Malignant Tumours. 6th edition, John Wiley & Sons, Inc., New York, NY, 2002.
20. Mukai M: Occult neoplastic cells and malignant microaggregates in lymph node sinuses: review and hypothesis. Oncol Rep 14: 173-175, 2005.
21. Mukai M, Tajima T, Nakasaki H, Sato S, Ogoshi K and Makuuchi H: Efficacy of postoperative adjuvant oral immunochemotherapy in patients with Dukes' B colorectal cancer. Ann Cancer Res Therap 11: 201-214, 2003. (Pubitemid 39334896)
22. Mukai M, Tajima T, Nakasaki H, Sato S, Ogoshi K and Makuuchi H: Efficacy of postoperative adjuvant oral immunochemotherapy in patients with Dukes' C colorectal cancer. Ann Cancer Res Therap 11: 215-229, 2003. (Pubitemid 39341153)
23. Enjoji A and the Nagasaki digestive organ cancer chemotherapy study group: Combination chemotherapy of 5-fluorouracil and low-dose Cisplatin in advanced and recurrent gastric cancer: a multicenter retrospective study in Nagasaki, Japan. Anticancer Res 22: 1135-1140, 2002.
24. Mukai M, Hinoki T, Tajima T, Sato S, Nakasaki H, Ogoshi K and Makuuchi H: Complete remission after combination chemotherapy for stage IV gastric cancer with peritoneal dissemination and liver matastases; case report. Ann Cancer Res Therap 11: 169-181, 2003. (Pubitemid 39334894)
25. Nakane PK and Pierce GB: Enzyme-labeled antibodies: preparation and application for localization of antigens. J Histochem Cytochem 14: 929-931, 1966.
26. Nakane PK and Pierce GB: Enzyme-labeled antibody for the light and electron microscopic localization of tissue antigens. J Cell Biol 33: 307-318, 1967.
27. National Institutes of Health Consensus Development Panel: National Institutes of Health consensus development conference statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 93: 979-989, 2001.
28. Abrams JS: Adjuvant therapy for breast cancer-results from the USA consensus conference. Breast Cancer 8: 298-304, 2001.
29. Mukai M, Sato S, Ninomiya H, Wakui K, Komatsu N, Tsuchiya K, Nakasaki H and Makuuchi H: Recurrence and 5-FU sensitivity of stage III/Dukes' C colorectal cancer with occult neoplastic cells in lymph node sinuses. Oncol Rep 14: 1165-1169, 2005.
30. Mukai M, Sato S, Ninomiya H, Wakui K, Komatsu N, Tsuchiya K, Nakasaki H and Makuuchi H: Recurrence and 5-FU sensitivity of stage II/Dukes' B colorectal cancer with occult neoplastic cells in lymph node sinuses. Oncol Rep 14: 1171-1176, 2005.
31. Mukai M, Sato S, Ninomiya H, Wakui K, Komatsu N, Tsuchiya K, Nakasaki H and Makuuchi H: Recurrence and 5-FU sensitivity of node-positive stage II/III gastric cancer with occult neoplastic cells in lymph node sinuses. Oncol Rep 14: 1505-1510, 2005.
32. Mukai M, Sato S, Ninomiya H, Wakui K, Komatsu N, Tsuchiya K, Nakasaki H and Makuuchi H: Recurrence and 5-FU sensitivity of stage I/II node-negative breast, lung, or gastric cancer with occult neoplastic cells in lymph node sinuses. Oncol Rep 15: 815-820, 2006.
33. Hasegawa S, Mukai M, Sato S, Tajima T, Wakui K, Ninomiya H, Komatsu N, Nakasaki N and Makuuchi H: Long-term survival and tumor 5-FU sensitivity in patients with stage IV colorectal cancer and peritoneal dissemination. Oncol Rep 15: 1185-1190, 2006.
34. Galandiuk S, Wieand HS, Moertel CG, Cha SS, Fitzgibbons RJ, Pemberton JH and Wolff BG: Pattern of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obst 174: 27-32, 1992.
35. Ambiru S, Miyazaki M, Ito H, Nakagawa K, Shimizu H, Kato A, Nakamura S, Omoto H and Nakajima N: Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer 82: 274-278, 1998. (Pubitemid 28060242)
36. Muramatsu T, Mukai M, Sato S, Tajima T, Nagase E, Ikeda M, Goya K, Shida M, Hirasawa T, Murakami and Shinozuka T: Clinical usefulness of serum and immunohistochemical markers in patients with stage Ia and Ic ovarian cancer. Oncol Rep 14: 861-865, 2005.
37. Feinstein AR, Sosin DM and Wells CK: The Will Rogers phenomenon: stage migration and new techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312: 1604-1608, 1985. (Pubitemid 15062653)
38. Bunt AMG, Hermans J, Smit VTHBM, van de Velde CJH, Fleuren GL and Bruijn JA: Surgical/pathologic stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 13: 19-25, 1995.